已收盤 10-17 16:00:00 美东时间
+3.570
+1.54%
Aligos Therapeutics announced that its management will present at the H.C. Wainwright Liver Disease Conference on October 21-22, 2025. The presentation can be accessed via webcast on Aligos' website, with a replay available for 30 days. Aligos is a clinical-stage biotech company focused on developing best-in-class therapies for liver and viral diseases such as chronic HBV, MASH, and coronaviruses.
10-14 12:30
Atlas Arteria ( ($AU:ALX) ) just unveiled an announcement. Atlas Arteria announ...
10-13 06:27
Atlas Arteria ( ($AU:ALX) ) just unveiled an announcement. Atlas Arteria has an...
10-10 10:18
Atlas Arteria ( ($AU:ALX) ) has provided an update. Atlas Arteria announced a d...
09-19 07:18
Atlas Arteria ( ($AU:ALX) ) just unveiled an announcement. Atlas Arteria has an...
09-19 07:18
Monopar Therapeutics Inc. (NASDAQ:MNPR) announced that new data on the long-term neurological efficacy and safety of its investigational therapy ALXN1840 (tiomolybdate choline) for Wilson disease will be presented at the
09-14 20:15
The latest update is out from ALX Oncology Holdings ( ($ALXO) ). On September 1...
09-12 20:57
Atlas Arteria ( ($AU:ALX) ) has issued an announcement. Atlas Arteria has annou...
09-09 14:23
Oppenheimer has initiated Monopar Therapeutics at outperform citing the potential of a candidate for the genetic disorder Wilson disease it acquired from AstraZeneca (AZN). The firm set a $77 price ta...
09-03 23:29
Atlas Arteria ( ($AU:ALX) ) has shared an announcement. Atlas Arteria has relea...
08-28 08:58